- Home
- CTRN vs PALI Comparison
CTRN vs PALI Comparison
Compare CTRN & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | PALI |
|---|---|---|
| Founded | 1946 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.7M | 268.6M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRN | PALI |
|---|---|---|
| Price | $41.86 | $1.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $52.00 | $16.00 |
| AVG Volume (30 Days) | 121.2K | ★ 5.0M |
| Earning Date | 12-02-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $800,741,000.00 | N/A |
| Revenue This Year | $8.16 | N/A |
| Revenue Next Year | $5.38 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.77 | N/A |
| 52 Week Low | $16.82 | $0.53 |
| 52 Week High | $49.50 | $2.59 |
Technical Indicators
Market Signals| Indicator | CTRN | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 48.28 |
| Support Level | $42.73 | $1.65 |
| Resistance Level | $48.49 | $2.27 |
| Average True Range (ATR) | 2.74 | 0.17 |
| MACD | -0.64 | -0.03 |
| Stochastic Oscillator | 33.65 | 28.23 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.